Back to funds

ACORN CAPITAL ADVISORS, LLC

Updated 6 days ago

Managed by Acorn Capital Advisors, Llc • Latest filing Q3 2026

Portfolio value
$364M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$295.1M
Q1 2026$351.8M
Q2 2026$366.5M
Q3 2026$364M

Top holdings

22 positions as of Q3 2026

View filing
C

CG ONCOLOGY INC

Value
$80.2M
Shares
1.13M
% Port
22.04%
U

UROGEN PHARMA LTD

Value
$67M
Shares
1.65M
% Port
18.40%
?
3.N/A

PUMA BIOTECHNOLOGY INC

Value
$41M
Shares
4.13M
% Port
11.27%
C

CANDEL THERAPEUTICS INC

Value
$36.5M
Shares
3.50M
% Port
10.03%
T

TREVI THERAPEUTICS INC

Value
$30.7M
Shares
2.14M
% Port
8.44%
H

HELUS PHARMA INC.

Value
$18.9M
Shares
1.54M
% Port
5.20%
J

JADE BIOSCEINCES INC

Value
$13.9M
Shares
986.8K
% Port
3.81%
B

BICARA THERAPEUTICS

Value
$12.4M
Shares
668.4K
% Port
3.42%
V

VERASTEM INC

Value
$11.8M
Shares
1.47M
% Port
3.25%
O

ONKURE THERAPEUTICS INC

Value
$7.8M
Shares
2.84M
% Port
2.13%
E

EUGENE THERAPEUTICS

Value
$7.6M
Shares
3.81M
% Port
2.09%
?
12.N/A

AN2 THERAPEUTICS

Value
$6.9M
Shares
1.30M
% Port
1.90%
A

AURA BIOSCIENCES INC

Value
$6.4M
Shares
1.03M
% Port
1.77%
T

PROTARA THERAPEUTICS INC

Value
$5.3M
Shares
1.75M
% Port
1.47%
A

ANNEXON INC.

Value
$4.8M
Shares
1.14M
% Port
1.32%
L

LEONABIO, INC.

Value
$4.1M
Shares
1.14M
% Port
1.12%
W

WHITEHAWK THERAPEUTICS INC

Value
$3.5M
Shares
932.1K
% Port
0.96%
Q

Q32 BIO INC.

Value
$1.8M
Shares
216.2K
% Port
0.49%
K

KARYOPHARM THERAPEUTICS INC

Value
$1.5M
Shares
1.22M
% Port
0.41%
J

JASPER THERAPEUTICS

Value
$834K
Shares
1.44M
% Port
0.23%

Explore